StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.77+0.03 (+1.09%)

Close on Nov 16, 2026Market cap $23.10MP/E –Yield –

Evaxion A/S profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was -102.4%, against -316.0% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-102.4%+213.6
FY2024Dec 31, 2024-316.0%+29992.2
FY2023Dec 31, 2023-30308.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2025Jun 30, 2025-13056.8%–
Q2 FY2024Jun 30, 2024-4024.7%–

More Evaxion A/S figures

See a number that looks wrong?